BREAst Cancer Personalised NuTrition (BREACPNT): dietary intervention in breast cancer survivors treated with endocrine therapy – a protocol for a randomised clinical trial
Introduction Breast cancer survivors treated with adjuvant endocrine therapy commonly experience weight gain, which has been associated with low adherence to therapy and worse breast cancer prognosis. We aim to assess whether a personalised postprandial glucose targeting diet will be beneficial for...
Main Authors: | Anastasia Godneva, Dmitry Kolobkov, Eran Segal, Michal Sela Rein, Maya Dadiani, Michal Bakalenik-Gavry, Dana Morzaev-Sulzbach, Yaeli Vachnish, maya Lotan-Pompan, Adina Weinberger, Einav Nili Gal-Yam |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-11-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/11/e062498.full |
Similar Items
-
Chemotherapy Shifts the Balance in Favor of CD8+ TNFR2+ TILs in Triple-Negative Breast Tumors
by: Tamir Baram, et al.
Published: (2021-06-01) -
Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial
by: Michal Rein, et al.
Published: (2022-02-01) -
Impact of dietary interventions on pre-diabetic oral and gut microbiome, metabolites and cytokines
by: Saar Shoer, et al.
Published: (2023-09-01) -
ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis
by: Adi Zundelevich, et al.
Published: (2020-02-01) -
Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis
by: Adi Zundelevich, et al.
Published: (2020-03-01)